Does VISMODEGIB Cause Basal cell carcinoma? 123 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 123 reports of Basal cell carcinoma have been filed in association with VISMODEGIB (ERIVEDGE). This represents 1.5% of all adverse event reports for VISMODEGIB.
123
Reports of Basal cell carcinoma with VISMODEGIB
1.5%
of all VISMODEGIB reports
7
Deaths
13
Hospitalizations
How Dangerous Is Basal cell carcinoma From VISMODEGIB?
Of the 123 reports, 7 (5.7%) resulted in death, 13 (10.6%) required hospitalization, and 2 (1.6%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
Yes, Basal cell carcinoma is listed as a known adverse reaction in the official FDA drug label for VISMODEGIB.
What Other Side Effects Does VISMODEGIB Cause?
Muscle spasms (1,937)
Alopecia (1,330)
Ageusia (958)
Fatigue (899)
Dysgeusia (706)
Weight decreased (688)
Nausea (669)
Decreased appetite (662)
Death (657)
Diarrhoea (446)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which VISMODEGIB Alternatives Have Lower Basal cell carcinoma Risk?
VISMODEGIB vs VITAMIN A
VISMODEGIB vs VITAMIN B
VISMODEGIB vs VITAMIN D NOS
VISMODEGIB vs VITAMINS
VISMODEGIB vs VOCLOSPORIN